Alison B Hamilton1, Sabine Oishi2, Elizabeth M Yano3, Cynthia E Gammage2, Nell J Marshall3, Maren T Scheuner4. 1. 1] VA HSR&D Center of Excellence for the Study of Healthcare Provider Behavior, VA Greater Los Angeles Healthcare System, Los Angeles, California, USA [2] Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA. 2. VA HSR&D Center of Excellence for the Study of Healthcare Provider Behavior, VA Greater Los Angeles Healthcare System, Los Angeles, California, USA. 3. 1] VA HSR&D Center of Excellence for the Study of Healthcare Provider Behavior, VA Greater Los Angeles Healthcare System, Los Angeles, California, USA [2] Department of Health Policy and Management, Jonathan and Karin Fielding School of Public Health, University of California, Los Angeles, Los Angeles, California, USA. 4. 1] VA HSR&D Center of Excellence for the Study of Healthcare Provider Behavior, VA Greater Los Angeles Healthcare System, Los Angeles, California, USA [2] Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA.
Abstract
PURPOSE: We sought to identify characteristics of genetic services that facilitate or hinder adoption. METHODS: We conducted semi-structured key informant interviews in five clinical specialties (primary care, medical oncology, neurology, cardiology, pathology/laboratory medicine) within 13 Veterans Administration facilities. RESULTS: Genetic services (defined as genetic testing and consultation) were not typically characterized by informants (n = 64) as advantageous for their facilities or their patients; compatible with organizational norms of low cost and high clinical impact; or applicable to patient populations or norms of clinical care. Furthermore, genetic services had not been systematically adopted in most facilities because of their complexity: knowledge of and expertise on genetic testing was limited, and organizational barriers to utilization of genetic services were formidable. The few facilities that had some success with implementation of genetic services had knowledgeable clinicians interested in developing services and organizational-level facilitators such as accessible genetic test-ordering processes. CONCLUSION: Adoption and implementation of genetic services will require a multilevel effort that includes education of providers and administrators, opportunities for observing the benefits of genetic medicine, strategies for reducing the complexity of genomic medicine, expanded strategies for accessing genetics expertise and streamlining utilization, and resources dedicated to assessing the value of genetic information for the outcomes that matter to health-care organizations.
PURPOSE: We sought to identify characteristics of genetic services that facilitate or hinder adoption. METHODS: We conducted semi-structured key informant interviews in five clinical specialties (primary care, medical oncology, neurology, cardiology, pathology/laboratory medicine) within 13 Veterans Administration facilities. RESULTS: Genetic services (defined as genetic testing and consultation) were not typically characterized by informants (n = 64) as advantageous for their facilities or their patients; compatible with organizational norms of low cost and high clinical impact; or applicable to patient populations or norms of clinical care. Furthermore, genetic services had not been systematically adopted in most facilities because of their complexity: knowledge of and expertise on genetic testing was limited, and organizational barriers to utilization of genetic services were formidable. The few facilities that had some success with implementation of genetic services had knowledgeable clinicians interested in developing services and organizational-level facilitators such as accessible genetic test-ordering processes. CONCLUSION: Adoption and implementation of genetic services will require a multilevel effort that includes education of providers and administrators, opportunities for observing the benefits of genetic medicine, strategies for reducing the complexity of genomic medicine, expanded strategies for accessing genetics expertise and streamlining utilization, and resources dedicated to assessing the value of genetic information for the outcomes that matter to health-care organizations.
Authors: June C Carroll; Tutsirai Makuwaza; Donna P Manca; Nicolette Sopcak; Joanne A Permaul; Mary Ann O'Brien; Ruth Heisey; Elizabeth A Eisenhauer; Julie Easley; Monika K Krzyzanowska; Baukje Miedema; Sandhya Pruthi; Carol Sawka; Nancy Schneider; Jonathan Sussman; Robin Urquhart; Catarina Versaevel; Eva Grunfeld Journal: Can Fam Physician Date: 2016-10 Impact factor: 3.275
Authors: Tessel Rigter; Lidewij Henneman; Jacqueline E W Broerse; Maggie Shepherd; Ignacio Blanco; Ulf Kristoffersson; Martina C Cornel Journal: J Community Genet Date: 2014-06-04
Authors: Caroline M Weipert; Kerry A Ryan; Jessica N Everett; Beverly M Yashar; Arul M Chinnaiyan; J Scott Roberts; Raymond De Vries; Brian J Zikmund-Fisher; Victoria M Raymond Journal: J Genet Couns Date: 2017-08-24 Impact factor: 2.537
Authors: Kristin W Weitzel; Amanda R Elsey; Taimour Y Langaee; Benjamin Burkley; David R Nessl; Aniwaa Owusu Obeng; Benjamin J Staley; Hui-Jia Dong; Robert W Allan; J Felix Liu; Rhonda M Cooper-Dehoff; R David Anderson; Michael Conlon; Michael J Clare-Salzler; David R Nelson; Julie A Johnson Journal: Am J Med Genet C Semin Med Genet Date: 2014-03-10 Impact factor: 3.908
Authors: Jeffrey R Botkin; John W Belmont; Jonathan S Berg; Benjamin E Berkman; Yvonne Bombard; Ingrid A Holm; Howard P Levy; Kelly E Ormond; Howard M Saal; Nancy B Spinner; Benjamin S Wilfond; Joseph D McInerney Journal: Am J Hum Genet Date: 2015-07-02 Impact factor: 11.025
Authors: S Harada; Y Zhou; S Duncan; A R Armstead; G M Coshatt; C Dillon; B C Brott; J Willig; J A Alsip; W B Hillegass; N A Limdi Journal: Clin Pharmacol Ther Date: 2017-06-01 Impact factor: 6.875
Authors: Maren T Scheuner; Kenute Myrie; Jane Peredo; Lori Hoffman-Hogg; Margaret Lundquist; Stephanie L Guerra; Douglas Ball Journal: Fed Pract Date: 2020-08
Authors: Barbara Lerner; Nell Marshall; Sabine Oishi; Andrew Lanto; Martin Lee; Alison B Hamilton; Elizabeth M Yano; Maren T Scheuner Journal: Genet Med Date: 2016-12-15 Impact factor: 8.822